Weekend reads: COVID-19 issue pulled; an author announces a retraction; FDA sanctions a company for not publishing results

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured:

Our list of retracted or withdrawn COVID-19 papers is up to 122.

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

Like Retraction Watch? You can make a one-time tax-deductible contribution or a monthly tax-deductible donation to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

One thought on “Weekend reads: COVID-19 issue pulled; an author announces a retraction; FDA sanctions a company for not publishing results”

  1. The Frontiers issue is scandalous. We should be looking in every available corner for Covid relief, but after approving the special issue in concept, the publisher rejected a request to more closely investigate cheap generics. Not even a recommendation for approval — just an encouragement of larger studies. Frontiers is funded by Bill and Melinda Gates Foundation, of course.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.